BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 14567452)

  • 1. Mass customization--the next generation of pharmacy management.
    Chao S
    Am J Manag Care; 2003 Sep; Suppl Decison Maker News():5-7. PubMed ID: 14567452
    [No Abstract]   [Full Text] [Related]  

  • 2. Specialty pharmacy management adjusts to new financial realities.
    Reinke T
    Manag Care; 2013 Apr; 22(4):13-4. PubMed ID: 23678558
    [No Abstract]   [Full Text] [Related]  

  • 3. Stats & facts. More consumer cost sharing in pharmacy benefit.
    Manag Care Interface; 2002 Apr; 15(4):34-5. PubMed ID: 11979701
    [No Abstract]   [Full Text] [Related]  

  • 4. Need for integrated data in pharmacy benefits.
    Martens G; Clor GE
    J Health Care Benefits; 1993; 3(1):57-60. PubMed ID: 10130352
    [No Abstract]   [Full Text] [Related]  

  • 5. Managed care organizations: an introduction--Part II of II.
    Vogenberg FR
    Hosp Pharm; 1995 Feb; 30(2):138, 140-2. PubMed ID: 10184282
    [No Abstract]   [Full Text] [Related]  

  • 6. Effective strategies for managing pharmacy benefits.
    Jacobson D
    Healthc Financ Manage; 2001 Mar; 55(3):41-2. PubMed ID: 11258270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four-dollar generics--increased accessibility, impaired quality assurance.
    Choudhry NK; Shrank WH
    N Engl J Med; 2010 Nov; 363(20):1885-7. PubMed ID: 21067379
    [No Abstract]   [Full Text] [Related]  

  • 8. Public payers foot greater pharmacy costs.
    Manag Care; 2006 Jul; 15(7):70. PubMed ID: 16898070
    [No Abstract]   [Full Text] [Related]  

  • 9. Designing and implementing an effective specialty pharmacy service program.
    Morrow TJ
    Manag Care Interface; 2003 Apr; 16(4):50-3. PubMed ID: 12747141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new method for determining patient payments for outpatient drugs.
    Goldman DP; Lakdawalla D
    Am J Manag Care; 2002 Feb; 8(2):125, 128, 130. PubMed ID: 11853200
    [No Abstract]   [Full Text] [Related]  

  • 11. The pitfalls and potential of pharmacy risk.
    Lawrence J
    Manag Care; 1998 May; 7(5):45-6, 51-2. PubMed ID: 10180140
    [No Abstract]   [Full Text] [Related]  

  • 12. Escalating need for comparative analysis of drugs within a therapeutic class.
    Giaquinta D
    Manag Care Interface; 2003 Oct; 16(10):32-4. PubMed ID: 14606258
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk contractors take aim at skyrocketing drug costs.
    Capitation Manag Rep; 1998 Sep; 5(9):129-34. PubMed ID: 10186047
    [No Abstract]   [Full Text] [Related]  

  • 14. The managed care prescription benefit. Challenged by shifting care and shifting costs.
    Bender J
    AAPPO J; 1991; 1(4):11-8. PubMed ID: 10149632
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacy benefits management and ambulatory pharmacy services.
    Strandberg LR
    Pharm Pract Manag Q; 1996 Jan; 15(4):19-26. PubMed ID: 10153841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing injectable drugs: an evolving challenge for pharmacy benefit managers.
    Giaquinta D
    Manag Care Interface; 2002 Dec; 15(12):15-6. PubMed ID: 12530291
    [No Abstract]   [Full Text] [Related]  

  • 17. Survey highlights trends in managing Medicare drug costs.
    Public Sect Contract Rep; 1998 Aug; 4(8):125-7. PubMed ID: 10182909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacy expenditures: the challenges of balancing access, cost, and value.
    Am J Manag Care; 2003 Jun; Suppl Decision Maker News():1-4. PubMed ID: 12866364
    [No Abstract]   [Full Text] [Related]  

  • 19. Cap for injectables not for the faint of heart.
    Capitation Rates Data; 2003 Jul; 8(7):79-81. PubMed ID: 12908211
    [No Abstract]   [Full Text] [Related]  

  • 20. Can e-prescribing reduce drug costs under capitation?
    Capitation Manag Rep; 2002 Apr; 9(4):58-62, 49. PubMed ID: 12004737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.